{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:13Z","timestamp":1792602853850,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2025,10,22]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Green tea contains a bioactive polyphenol called epigallocatechin gallate (EGCG), which\nmay be used as a therapeutic agent for breast cancer (BC). This review examines the pharmacological\nand chemical properties of EGCG, which may make it a valuable therapeutic agent for treating\nbreast cancer. The distinctive physicochemical characteristics of EGCG, such as its solubility, stability,\nand bioavailability, are based on its molecular structure, which is also crucial for its medicinal\nuses. Furthermore, the availability of EGCG as a naturally occurring substance, its production in\n\"Camellia sinensis,\" and the use of sophisticated extraction methods are also covered. Apoptosis is\ninduced via caspase activation and mitochondrial failure. Metastasis-related enzymes are inhibited,\nand key signaling pathways, including PI3k, Akt, and MAPK, are modulated as part of EGCG's multifaceted\nanti-cancer actions. The synergistic benefits of EGCG with traditional chemotherapies, in\ncombating drug resistance and enhancing their effectiveness, significantly improve the therapeutic\nvalue of these treatments. Limited bioavailability is addressed via liposomal delivery, nanoparticle\nencapsulation, and structural optimisation. Pharmacokinetics, toxicology, and clinical studies all\nsupport its safety and effectiveness. This study highlights the promise of EGCG as a therapeutic\nagent for breast cancer, exploring its molecular interactions, new formulations, and the integration of\nchemistry and molecular mechanisms to enhance EGCG's therapeutic applicability in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115748871386534251004122533","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:30:27Z","timestamp":1761305427000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chemical Perspectives on Epigallocatechin-3-Gallate (EGCG): Mechanisms and Therapeutic Potential in Breast Cancer Treatment"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2041-9325","authenticated-orcid":true,"given":"Sakshi","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Medical &amp; Allied Sciences, Galgotias University, Greater Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K .","family":"Abdul Rahaman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical &amp; Allied Sciences, Galgotias University, Greater Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3797-1575","authenticated-orcid":true,"given":"Prem Shankar","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical &amp; Allied Sciences, Galgotias University, Greater Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0237-3201","authenticated-orcid":true,"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical &amp; Allied Sciences, Galgotias University, Greater Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871386534251004122533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/246417\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871386534251004122533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:30:34Z","timestamp":1761305434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/246417\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871386534251004122533","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}